Home688266 • SHA
add
Suzhou Zelgen Biopharmaceuticals Co Ltd
Nakaraang pagsara
¥107.32
Sakop ng araw
¥107.89 - ¥113.62
Sakop ng taon
¥58.00 - ¥134.17
Market cap
28.31B CNY
Average na Volume
3.31M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Mga balita tungkol sa merkado
Bloomberg.com
51 minuto ang nakalipas
Asian Stocks to Gain as Bets for Fed Rate Cut Rise: Markets Wrap
0.41%
0.30%
0.86%
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 217.79M | 51.85% |
Gastos sa pagpapatakbo | 208.28M | 18.06% |
Net na kita | -20.61M | 34.29% |
Net profit margin | -9.46 | 56.74% |
Kita sa bawat share | — | — |
EBITDA | 5.70M | 118.01% |
Aktuwal na % ng binabayarang buwis | 4.20% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.09B | -5.32% |
Kabuuang asset | 3.01B | 1.56% |
Kabuuang sagutin | 1.86B | 12.02% |
Kabuuang equity | 1.15B | — |
Natitirang share | 264.71M | — |
Presyo para makapag-book | 24.73 | — |
Return on assets | -0.42% | — |
Return on capital | -0.55% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -20.61M | 34.29% |
Cash mula sa mga operasyon | 286.35K | 100.62% |
Cash mula sa pag-invest | -4.21M | 84.48% |
Cash mula sa financing | -26.60M | 78.29% |
Net change in cash | -30.60M | 84.40% |
Malayang cash flow | -94.18M | -230.43% |
Tungkol
Itinatag
Mar 18, 2009
Website
Mga Empleyado
910
